Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937923 · ClinicalTrials.gov registry record
A Pre-Cellular Therapy Observational Study in Early Huntington's Disease
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 29
- Enrollment target
NCT01937923 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 29 participants.
The verdict
NCT01937923 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This observational study will establish a clinical baseline and measure changes over time in movement, thinking, behavior, brain imaging, blood and spinal fluid markers in subjects with early stage Huntington's disease. Participants enrolled in this study may be eligible to participate in a future planned study of stem cell therapy for Huntington's Disease (HD). In-person study visits occur at screening, baseline, and every 6 months thereafter for a minimum of 12 months, with interim phone call assessments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01937923
The ClinicalTrials.gov registry entry for NCT01937923 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01937923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01937923 about?
NCT01937923 is a clinical study titled "A Pre-Cellular Therapy Observational Study in Early Huntington's Disease". This observational study will establish a clinical baseline and measure changes over time in movement, thinking, behavior, brain imaging, blood and spinal fluid markers in subjects with early stage Huntington's disease. Participants enrolled in this study may be eligible to participate in a future p...
What is the current status of trial NCT01937923?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2013-08. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01937923?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.